REIMAGINE IMAGING
Sustainable Capacity Relief Through Innovative Autonomous Diagnostics
The Dutch healthcare sector is facing immense pressure due to an aging population and a shrinking workforce.
REIMAGINE IMAGING is a public-private program accelerating the development of autonomous MRI and ultrasound technologies. By combining smart hardware with Artificial Intelligence (AI), the program enables faster, more efficient, and patient-friendly diagnostics, bringing high-quality medical imaging closer to the patient, both at clinical gatekeepers and in primary care settings.
The Challenge: Faster Diagnostics, Smarter Care
Current specialized care is often hindered by long waiting times and a heavy reliance on expensive infrastructure. REIMAGINE IMAGING breaks this cycle by supporting public-private consortia in developing scientifically validated innovations. The program focuses on four high-impact medical areas:
- Breast Cancer: Dedicated MRI in mobile units to improve early detection for women with dense breast tissue.
- Prostate Cancer: Using MRI as a first-line triage tool to prevent painful biopsies and reduce healthcare costs.
- Vascular Dementia: Autonomous brain MRI scans to enable timely diagnosis and offer clarity to caregivers in elderly care.
- Abdominal Complaints: AI-supported handheld ultrasound for general practitioners to allow immediate triage, preventing unnecessary hospital referrals.
Empowering Future Consortia
The program addresses four essential needs for innovative companies and SMEs looking to scale their medical technology:
- Validation: Access to healthcare professionals, patients, and data for reliable clinical testing.
- System Integration: Combining technologies from multiple partners to create complete, deployable solutions.
- Scalability: Facilitating rapid market entry through partners with international sales channels and production capacity.
- Risk Reduction: PPS contributions make major innovation steps achievable with limited private investment.
Impact and Future-Proof Healthcare
By advancing technologies from experimental development to clinical demonstration, REIMAGINE IMAGING delivers structural results:
- Workforce Support: AI-driven imaging can potentially reduce the time burden on laboratory staff by up to 50% and on radiologists by 40%.
- Accessibility: Moving diagnostics to GP practices and nursing homes ensures the right triage at the right place.
- Economic Value: Strengthening the Dutch export position in a global imaging market.
Program Group
The REIMAGINE IMAGING program is managed and coordinated by the following core organizations:
- High Tech NL: Communication, Valorization & Congresses.
- Maastricht University: Quality and Planning.
- Philips Healthcare: Market and Commercialization.
- University Medical Center Utrecht (UMCU): Coordination, Finance, and Administration.
Discover the Future of Autonomous Diagnostics
Do you want to know more about the technological innovations, the selection procedure, or how you can contribute to sustainable healthcare capacity? Visit the official website for all details and updates regarding the program.
